Hide metadata

dc.date.accessioned2018-06-18T14:32:54Z
dc.date.available2018-06-18T14:32:54Z
dc.date.issued2018
dc.identifier.urihttp://hdl.handle.net/10852/61901
dc.language.isoenen_US
dc.relation.haspartPaper 1: Sahraoui A, Kloster-Jensen K, Ueland T, Korsgren O, Foss A, Scholz H. Anakinra and tocilizumab enhance survival and function of human islets during culture: implications for clinical islet transplantation. Cell Transplant. 2014;23(10):1199-211. The paper is not available in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.3727/096368913X667529
dc.relation.haspartPaper 2: Kloster-Jensen K, Sahraoui A, VetheNT, KorsgrenO, Bergan S, FossA, and Scholz H. Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids. J Diabetes Res. 2016;2016:4196460 (epub 2016 Jan 18). The paper is available in DUO: http://hdl.handle.net/10852/54656
dc.relation.haspartPaper 3: Kloster-Jensen K, VetheNT, Bremer S, Abadpour S, KorsgrenO, Bergan S, FossA and Scholz H. Intracellular sirolimus concentration decrease in combination with tacrolimus exposure of human islets in vitro. Transpl Int. 2015 Oct;28(10):1152-61. The paper is not available in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1111/tri.12617
dc.relation.urihttps://doi.org/10.3727/096368913X667529
dc.relation.urihttp://hdl.handle.net/10852/54656
dc.relation.urihttps://doi.org/10.1111/tri.12617
dc.titleFunctional in vitro studies of immunosuppressive agents in human pancreatic isletsen_US
dc.typeDoctoral thesisen_US
dc.creator.authorKloster-Jensen, Kristine
dc.identifier.urnURN:NBN:no-64499
dc.type.documentDoktoravhandlingen_US
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/61901/1/PhD-Kloster-Jensen-DUO.pdf


Files in this item

Appears in the following Collection

Hide metadata